comparemela.com
  1. Home
  2. Live Updates
  3. Metastasis Free Survival - Breaking News

Latest Breaking News On - Metastasis free survival - Page 1 : comparemela.com

nmCRPC: Clinical Trial Data on AR Inhibitors

Shared insight on the SPARTAN, PROSPER, and ARAMIS studies with androgen receptor (AR) inhibitors in non-metastatic castration-resistant prostate cancer.

Key updatesMetastatic prostate cancer treatmentClinical trial dataProstate cancerNonmetastatic castration resistant prostate cancerSpartan trialSpartan studyProsper trialProsper studyAramis trialAramis studyMetastasis free survivalMfs survivalOverall survivalSurvival dataAr inhibitors

Goals of Treatment for Non-metastatic Castration-Resistant Prostate Cancer

Expert oncologists provide a focused review on goals of therapy for patients with non-metastatic castration-resistant prostate cancer (nmCRPC).

Key updatesMetastatic prostate cancer treatmentNon metastatic castration resistant prostateProstate cancerNonmetastatic castration resistant prostate cancerMetastasis free survivalMfs survivalPsa doublingPsa doubling timeProstate cancer imagingPsma petPsma pet scan

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.